{"id":"https://openalex.org/W2004740907","doi":"https://doi.org/10.1007/bf02005767","title":"Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: Implications for biological regulation of 5-lipoxygenase","display_name":"Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: Implications for biological regulation of 5-lipoxygenase","publication_year":1994,"publication_date":"1994-11-01","ids":{"openalex":"https://openalex.org/W2004740907","doi":"https://doi.org/10.1007/bf02005767","mag":"2004740907","pmid":"https://pubmed.ncbi.nlm.nih.gov/7741044"},"language":"en","primary_location":{"id":"doi:10.1007/bf02005767","doi":"https://doi.org/10.1007/bf02005767","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf02005767","pdf_url":null,"source":{"id":"https://openalex.org/S55943811","display_name":"Inflammation Research","issn_l":"1023-3830","issn":["1023-3830","1420-908X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Agents and Actions","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026146238","display_name":"Armin Hatzelmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Hatzelmann","raw_affiliation_strings":["Bayer AG, Pharma Research Center, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Pharma Research Center, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079870410","display_name":"Romanis Fruchtmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R. Fruchtmann","raw_affiliation_strings":["Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014901333","display_name":"Klaus Mohrs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K. H. Mohrs","raw_affiliation_strings":["Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040038065","display_name":"Siegfried Raddatz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S. Raddatz","raw_affiliation_strings":["Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Matzke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Matzke","raw_affiliation_strings":["Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051072630","display_name":"U. Plei\u00df","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U. Pleiss","raw_affiliation_strings":["Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111838899","display_name":"J\u00f6rg Keldenich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J. Keldenich","raw_affiliation_strings":["Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068439786","display_name":"Reiner M\u00fcller-Peddinghaus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R. M\u00fcller-Peddinghaus","raw_affiliation_strings":["Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, P.O. Box 101709, D-42096, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer AG Pharma Research Center, Institute for Cardiovascular and Arteriosclerosis Research, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I67348948"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.6225,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.84303797,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"43","issue":"1-2","first_page":"64","last_page":"68"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.7689999938011169,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.7689999938011169,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.20520000159740448,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leukotriene-synthesis-inhibitors","display_name":"leukotriene synthesis inhibitors","score":0.9559999704360962},{"id":"https://openalex.org/keywords/flaps","display_name":"flaps","score":0.753000020980835},{"id":"https://openalex.org/keywords/leukotriene-b4","display_name":"leukotriene B4","score":0.8579999804496765},{"id":"https://openalex.org/keywords/substrate-transfer","display_name":"substrate transfer","score":0.5839999914169312},{"id":"https://openalex.org/keywords/arachidonic-acid","display_name":"arachidonic acid","score":0.8730000257492065},{"id":"https://openalex.org/keywords/allergic-asthma","display_name":"allergic asthma","score":0.5759999752044678},{"id":"https://openalex.org/keywords/mk-886","display_name":"MK-886","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C2776452501","wikidata":"https://www.wikidata.org/wiki/Q424190","display_name":"Leukotriene","level":3,"score":0.7247219085693359},{"id":"https://openalex.org/C90342290","wikidata":"https://www.wikidata.org/wiki/Q94234745","display_name":"Arachidonate 5-lipoxygenase","level":4,"score":0.6296700835227966},{"id":"https://openalex.org/C2776352991","wikidata":"https://www.wikidata.org/wiki/Q407680","display_name":"Eicosanoid","level":4,"score":0.5832786560058594},{"id":"https://openalex.org/C2780857362","wikidata":"https://www.wikidata.org/wiki/Q1827455","display_name":"Lipoxygenase","level":3,"score":0.5507845878601074},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.542446494102478},{"id":"https://openalex.org/C98539663","wikidata":"https://www.wikidata.org/wiki/Q220599","display_name":"Cytosol","level":3,"score":0.4670115113258362},{"id":"https://openalex.org/C2779630222","wikidata":"https://www.wikidata.org/wiki/Q65658502","display_name":"Hydroxyeicosatetraenoic acid","level":4,"score":0.45250874757766724},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.4439318776130676},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.43759700655937195},{"id":"https://openalex.org/C192527728","wikidata":"https://www.wikidata.org/wiki/Q1465700","display_name":"Indole test","level":2,"score":0.415168821811676},{"id":"https://openalex.org/C2778078955","wikidata":"https://www.wikidata.org/wiki/Q407699","display_name":"Arachidonic acid","level":3,"score":0.39936959743499756},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.38692542910575867},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3811032772064209},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.37466156482696533},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26508066058158875},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20350435376167297},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.11072883009910583},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001094","descriptor_name":"Arachidonate 5-Lipoxygenase","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D001094","descriptor_name":"Arachidonate 5-Lipoxygenase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015289","descriptor_name":"Leukotrienes","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D020024","descriptor_name":"Leukotriene Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf02005767","doi":"https://doi.org/10.1007/bf02005767","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf02005767","pdf_url":null,"source":{"id":"https://openalex.org/S55943811","display_name":"Inflammation Research","issn_l":"1023-3830","issn":["1023-3830","1420-908X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Agents and Actions","raw_type":"journal-article"},{"id":"pmid:7741044","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7741044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Agents and actions","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W84643873","https://openalex.org/W1136706660","https://openalex.org/W1496063181","https://openalex.org/W1509307264","https://openalex.org/W1517088677","https://openalex.org/W1520264805","https://openalex.org/W1607954829","https://openalex.org/W1968575019","https://openalex.org/W1968792529","https://openalex.org/W1994730705","https://openalex.org/W1999783546","https://openalex.org/W2014768234","https://openalex.org/W2029059069","https://openalex.org/W2038575244","https://openalex.org/W2040062751","https://openalex.org/W2051010723","https://openalex.org/W2064700667","https://openalex.org/W2065297082","https://openalex.org/W2067595559","https://openalex.org/W2072993592","https://openalex.org/W2081186572","https://openalex.org/W2089338169","https://openalex.org/W2120133370","https://openalex.org/W2121737195","https://openalex.org/W2132713143","https://openalex.org/W2252978673","https://openalex.org/W2335169562","https://openalex.org/W2414834571","https://openalex.org/W2589310007"],"related_works":["https://openalex.org/W272373211","https://openalex.org/W2335169562","https://openalex.org/W73825595","https://openalex.org/W1971572251","https://openalex.org/W4410267927","https://openalex.org/W762928327","https://openalex.org/W2734973925","https://openalex.org/W112683668","https://openalex.org/W1999783546","https://openalex.org/W2320240919"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}